The open index of psychedelic research

Understanding experiences of psychedelic treatments for eating disorders: a meta-synthesis of qualitative studies.

Morris R, Gundogan A, Lawrence V +3

Child and maternal health outcomes following antenatal exposure to classic psychedelic substances: a systematic review

Sun S, Hanson C, Hendricks PS +9

Integration of the Psychedelic Experience Among Brazilians: A Survey Study.

Garcia ACM, Maia LO, Meireles E +2

Association Between Lifetime Hallucinogen Use and Valvular Heart Disease: Findings from the All of Us Research Program.

Yang KH, Rasmussen M, Bhatt K +4

The Therapeutic Alliance's Moderating Role on the Negative Relationship Between Dread of Ego Dissolution and Changes in Depression in Psilocybin-Assisted Therapy for Treatment-Resistant Depression.

MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use Disorder

Appetite for change: How nutritional state and ventral striatal dopamine shape psilocybin effects on cognitive flexibility

Conn K, Wong N, Sunnetci S +8

Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.

Corrigendum to: "Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia's clinical landscape".

Locomotor and discriminative stimulus effects of N-cyclohexyl butylone and N-cyclohexyl methylone.

Gatch MB, Jia S, Shetty RA +3

Classic psychedelics and autism spectrum disorder: preclinical evidence, mechanistic insights and unresolved challenges.

Ascone F, Giangiacomo D, Trezza V

Experimental Effects of Psychedelic Substance Type

One-shotted: Psychedelic insights are uniquely intense, meaningful, and ineffable

Efficacy and Safety of Adjunctive Therapy Using Single High-Dose S-Ketamine Infusion for Fibromyalgia: A Multicenter, Prospective, Randomized, Controlled, Open-Label, Blinded-Endpoint Study Protocol.

Shrestha N, Liu M, Niu S +4

Clinical Predictors of Antidepressant Effects of Ketamine and Esketamine in Treatment-Resistant Unipolar and Bipolar Depression: A Systematic Review.

Syed OA, Sobolenko V, Nestor SM +4

Subjective Experience Following Psilocybin

Strong alliance, weak conclusions: Comment on Goodwin et al. (2026) “The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression”

Wolff M, Kangaslampi S, Zeifman R +1

The Effect of Intraoperative Esketamine Infusion on Pruritus in Elderly Surgical Patients

Metabolomic shifts in beef steers rotationally grazing toxic endophyte-infected tall fescue under fall conditions.

Llada IM, Lourenco JM, Dycus MM +7

Mapping narrative reports of drug induced experiences: A data-driven dictionary-based approach.

Rennie JP, Morgan C

Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care.

Geller JA, Pacilio R, Downey AE +4

Aggregate Dataset for Reddit Discussions of Oral and Sublingual Ketamine Therapy

Alvear, Michael

Toward Integrating Intranasal Esketamine with Traumatic-Memory Psychotherapy in Treatment-Resistant Depression: A Narrative Review and Feasibility-Oriented Protocol Proposal.

Raffone F, Cattaneo CI, Pessina E +2

Reframing distress in oncology: the potential of psychedelic-assisted therapy.

Moujahid FZ, Taymans O